Genomind is a pharmacogenetic testing service that uses a cheek swab sample to identify a person's unique genetic markers that may indicate how they respond to medications.

Transcranial magnetic stimulation (TMS) is a noninvasive form of brain stimulation for treatment resistant depression.

Spravato (esketamine) is a inhalational nasal spray that is indicated for treatment resistant depression.